Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin-Reference-Cited by-同舟云学术

Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin

Published:2016 Issue:4 Volume:13 Page:310-315
ISSN:1449-1907
Container-title:International Journal of Medical Sciences
language:en
Short-container-title:Int. J. Med. Sci.

Author:

Kanda Tatsuo,Nakamoto Shingo,Sasaki Reina,Nakamura Masato,Yasui Shin,Haga Yuki,Ogasawara Sadahisa,Tawada Akinobu,Arai Makoto,Mikami Shigeru,Imazeki Fumio,Yokosuka Osamu

Publisher

Ivyspring International Publisher

Subject

General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Transplantation from a Human Leukocyte Antigen-Matched Sibling Donor: Effectiveness of Direct-Acting Antiviral Therapy against Hepatitis C Virus Infection;Reports;2022-12-04

2. Real Life Egyptian Experience of Daclatasvir Plus Sofosbuvir with Ribavirin in Naïve Difficult to Treat HCV Patients;Infectious Disorders - Drug Targets;2020-02-14

3. Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens;The Egyptian Journal of Internal Medicine;2019-12

4. Follow-up Results of HCV GT2 Patients After Sofosbuvir/Ribavirin Therapy: Careful Attention to Occurrence of HCC;Anticancer Research;2019-07

5. Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b;World Journal of Gastroenterology;2017-12-14